Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease
Mei-xi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zong‐Gen Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuhuan Li(Anhui Medical University), Xue-kai Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiali Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Huiqiang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Lei(Chinese Academy of Medical Sciences & Peking Union Medical College), Hu Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Biao Dong(Beijing Technology and Business University), Hongying Li(Kingston University), Nannan Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Mei Tang(Sichuan University), Jianrui Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Han Sun, Haiyan Yan(Sun Yat-sen University), Jing Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University)
Cited by 7
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
|Cell|2016|277
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
|Signal Transduction and Targeted Therapy|2021|210